Innate Pharma S.A. (EPA: IPH)

Innate Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	124	211	264	352	273	468
Market Cap Growth	-34.42%	-19.93%	-24.98%	28.64%	-41.60%	-1.49%
Enterprise Value	67	163	184	249	144	308
Last Close Price	1.53	2.62	3.29	4.45	3.46	5.96
Forward PE	6.30	-	-	-	-	-
PS Ratio	3.65	3.43	4.57	14.24	3.92	5.48
PB Ratio	4.30	4.07	4.87	3.27	1.75	2.15
P/TBV Ratio	5.29	4.10	5.02	5.56	2.49	3.89
P/FCF Ratio	-	-	-	-	-	13.91
P/OCF Ratio	-	-	-	-	-	13.40
EV/Sales Ratio	1.99	2.64	3.19	10.07	2.07	3.61
EV/EBITDA Ratio	-	-	-	-	10.86	17.87
EV/EBIT Ratio	-	-	-	-	133.87	195.73
EV/FCF Ratio	-3.67	-	-	-	-	9.16
Debt / Equity Ratio	1.23	0.77	0.78	0.41	0.12	0.09
Debt / EBITDA Ratio	-	-	-	-	1.33	1.03
Debt / FCF Ratio	-	-	-	-	-	0.56
Asset Turnover	0.19	0.31	0.24	0.09	0.20	0.20
Quick Ratio	2.76	3.51	3.21	1.67	3.64	1.90
Current Ratio	2.92	3.73	3.38	1.73	3.81	1.95
Return on Equity (ROE)	-78.59%	-14.28%	-71.75%	-34.53%	-0.44%	4.09%
Return on Assets (ROA)	-13.76%	-4.04%	-4.32%	-10.40%	0.19%	0.23%
Return on Capital (ROIC)	-29.62%	-8.41%	-8.28%	-18.30%	0.33%	0.48%
Earnings Yield	-27.60%	-3.58%	-22.02%	-15.02%	-23.41%	-4.43%
FCF Yield	-14.86%	-15.58%	-7.46%	-16.89%	-19.27%	7.19%
Buyback Yield / Dilution	-1.01%	-1.02%	-0.12%	-0.77%	-17.97%	-13.83%
Total Shareholder Return	-1.01%	-1.02%	-0.12%	-0.77%	-17.97%	-13.83%

Source: S&P Capital IQ. Standard template. Financial Sources.